MEDBOX | Toolbox Hepatitis

TOOLBOX

Advanced search

Create your MEDBOX

TOOLBOX

Advanced search

Create your MEDBOX

LIST OPTIONS

FILTER BY LANGUAGE

SORT BY

RESULTS/PAGE

LIST TYPE

8 records

	Recommandations et orientations concernant l’autodépistage du virus de l’hépatite C World Health Organisation (WHO) (2021) C_WHO View PDF(38) Download (30) Add to my MEDBOX Malgré les progrès récents vers la mise au point d’un traitement hautement efficace et abordable contre le virus de l’hépatite C, beaucoup de personnes infectées par ce virus ne connaissent pas leur statut. L’Organisation mondiale de la Santé (OMS) estime qu’en 2019, 58 millions de personnes à travers le monde étaient atteintes d’une infection chronique par le virus de l’hépatite C, et qu’à peine 21 % d’entre elles avaient été diagnostiquées. Le défaut de sensibilisation, l’accès limité aux services de dépistage et de traitement, la stigmatisation, la discrimination et d’autres obstacles structurels contribuent au faible taux d’utilisation des services de dépistage du virus de l’hépatite C Tags: l'autodépistage, recommendations, Hepatitis C, virus, Source: https://apps.who.int/iris/bitstream/hand
	Скрининг и лечение гепатита С среди пациентов с лекарственно-устойчивым туберкулезом в Армении Оганна Киракосян Médecins Sans Frontières (2018) C2 View PDF(77) Download (46) Add to my MEDBOX Презентация на тему значимости скрининга больных с лекарственно-устойчивым туберкулезом на гепатит С. Как ��учше всего лечить этих пациентов от гепатита С Tags: туберкулез, лечения туберкулеза, лекарственно-устойчивый туберкулез, гепатит С, презентация, скрининг, Армения, Source: http://msf-tb-symposium.org/files/7115/2
	Stratégie mondiale du secteur de la santé contre l'hépatite virale 2016-2021: vers l'élimination de l'hépatite virale Organisation mondiale de la Santé (OMS) (2016) C_WHO View PDF(612) Download (410) Add to my MEDBOX Le présent document énonce la première stratégie mondiale du secteur de la santé contre l’hépatite virale, une stratégie qui contribue à la réalisation du Programme de développement durable à l’horizon 2030. Elle couvre les six premières années du plan d’action pour la santé de l’après-2015, c’est-à-dire la période 2016-2021, en s’appuyant sur le document Prévention et lutte contre l’hépatite virale : cadre pour l’action mondiale et sur deux résolutions relatives à l’hépatite virale adoptées par l’Assemblée mondiale de la Santé en 2010 et en 2014. Cette stratégie porte sur les cinq virus de l’hépatite (les hépatites A, B, C, D et E), en mettant plus spécialement l’accent sur les hépatites B et C en raison de la lourde charge relative qu’elles représentent pour la santé publique Tags: health sector policy, disease control, Hepatitis, politique sectorielle de santé, contrôle de maladies, hépatite, Source: https://apps.who.int/iris/bitstream/hand
	Guidelines for the screening, care and treatment of persions with hepatitis C infection. Updated Version, April 2016 World Health Organization WHO (2016) C_WHO View PDF(2546) Download (1518) Add to my MEDBOX The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV genotype and clinical history, and assess the appropriateness of continued use of certain medicines. This document also includes existing recommendations on screening for HCV infection and care of persons infected with HCV that were first issued in 201 Tags: hepatitis C, Source: https://apps.who.int/iris/bitstream/1066
	Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection World Health Organization (2015) C_WHO View PDF(2290) Download (1362) Add to my MEDBOX The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those with most advanced liver disease and at greatest risk of mortality; and recommend the preferred use of nucleos(t)ide analogues with a high barrier to drug resistance (tenofovir and entecavir, and entecavir in children aged 2–11 years) for first- and second-line treatment. Recommendations for the treatment of HBV/HIV-coinfected persons are based on the WHO 2013 Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, which will be updated in 2015 Tags: Hepatitis, hepatitis B, care and treatment, Source: https://apps.who.int/iris/bitstream/1066
	Short Guide to Hepatitis C Stefan Mauss, Thomas Berg, Jürgen Rockstroh et al. Flying Publisher (2014) C2 View PDF(1711) Download (2202) Add to my MEDBOX Exciting new treatment approaches make the management of hepatitic C one of the most rapidly developing areas of medicine. The Flying Publisher short Guide to Hepatitis C is an up-to-date source of information for physicians, residents and advanced medical students Tags: Hepatitis, Source: http://pdf.flyingpublisher.com/Hepatitis
	Waterborne Outbreaks of Hepatitis E: recognition, investigation and control World Health Organization (WHO) (2014) C_WHO View PDF(599) Download (320) Add to my MEDBOX Technical report This manual aims to provide information about the methods for investigating outbreaks of hepatitis E, and measures for their prevention and control. In addition, the manual gives information about the causative agent – known as the hepatitis E virus (HEV) – its epidemiology, clinical manifestations of the disease and diagnosis Tags: investigation, hepatitis outbreak, hepatitis E, Disease Prevention and Control, disease response, Source: https://apps.who.int/iris/bitstream/hand
	Hepatitis B (chronic): Diagnosis and management of chronic hepatitis B in children, young people and adults Aftab Ala, Elizabeth Boxall, Steven Bradley et al. National Clinical Guideline Centre (2013) C2 Open external link (2643) Add to my MEDBOX Clinical guideline, Methods, Evidence and Recommendations In this guideline the following is covered: information needs of people with chronic hep titis B and their carers; where children, young people and adults with chronic hepatitis B a- should be assessed; assessment of liver disease, including the use of non-invasive tests and genotype testing; criteria for offering antiviral treatment; the efficacy, safety and cost effectiveness of currently available treatments; selection of first-line therapy; management of treatment failure or drug resistance; prophylactic treatment during im- munosuppressive therapy; and monitoring for treatment respons Tags: hepatitis B, Source: https://www.ncbi.nlm.nih.gov/books/NBK25

8 records

8 records